GHAM
TMO icon

Gilman Hill Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Gilman Hill Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$7.89M Sell
11,682
-72
-0.6% -$42.8K 1.1% 36
2026
Q2 		$5.89M Buy
11,754
+3,386
+40% +$1.63M 0.81% 51
2026
Q1 		$4.11M Buy
8,368
+365
+5% +$198K 0.62% 68
2025
Q4 		$4.64M Buy
8,003
+897
+13% +$507K 0.73% 65
2025
Q3 		$3.45M Buy
7,106
+178
+3% +$82.9K 0.54% 75
2025
Q2 		$2.81M Buy
6,928
+125
+2% +$52.3K 0.46% 76
2025
Q1 		$3.39M Buy
6,803
+48
+0.7% +$26K 0.59% 67
2024
Q4 		$3.51M Buy
6,755
+273
+4% +$150K 0.61% 65
2024
Q3 		$4.01M Buy
6,482
+46
+0.7% +$27.2K 0.67% 58
2024
Q2 		$3.56M Buy
6,436
+79
+1% +$45.3K 0.64% 65
2024
Q1 		$3.69M Buy
6,357
+33
+0.5% +$18.5K 0.66% 59
2023
Q4 		$3.36M Sell
6,324
-23
-0.4% -$11.1K 0.62% 58
2023
Q3 		$3.21M Buy
6,347
+148
+2% +$78.9K 0.63% 57
2023
Q2 		$3.23M Buy
6,199
+169
+3% +$91.2K 0.6% 60
2023
Q1 		$3.48M Buy
6,030
+395
+7% +$223K 0.71% 53
2022
Q4 		$3.1M Buy
5,635
+958
+20% +$508K 0.64% 54
2022
Q3 		$2.37M Sell
4,677
-67
-1% -$37.5K 0.55% 58
2022
Q2 		$2.58M Buy
4,744
+559
+13% +$308K 0.55% 53
2022
Q1 		$2.47M Buy
4,185
+478
+13% +$275K 0.56% 60
2021
Q4 		$2.47M Sell
3,707
-75
-2% -$46.8K 0.55% 57
2021
Q3 		$2.16M Buy
3,782
+35
+0.9% +$19.2K 0.55% 62
2021
Q2 		$1.89M Buy
3,747
+826
+28% +$390K 0.48% 65
2021
Q1 		$1.33M Buy
2,921
+533
+22% +$254K 0.37% 76
2020
Q4 		$1.11M Buy
2,388
+148
+7% +$69.4K 0.36% 80
2020
Q3 		$989K Sell
2,240
-190
-8% -$78.5K 0.38% 72
2020
Q2 		$880K Sell
2,430
-8
-0.3% -$2.68K 0.35% 77
2020
Q1 		$691K Buy
+2,438
New +$769K 0.34% 85

Other funds holding TMO

SP
Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return
CIPU
Caledonia Investments plc (UK) London England, United Kingdom $890M AUM 1.23% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

Gilman Hill Asset Management's TMO Position: Q3 2026 in Review

Gilman Hill Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 0.61% in Q3 2026, selling an estimated $42.8K and leaving 11,682 shares worth $7.89M. The position accounts for 1.1% of the portfolio, ranked #36.

Gilman Hill Asset Management first reported a position in TMO in Q1 2020 and has held it in 27 quarters since. 302 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Gilman Hill Asset Management held 11,682 shares of Thermo Fisher Scientific worth $7.89M as of Q3 2026.
  • Gilman Hill Asset Management sold 72 Thermo Fisher Scientific shares in Q3 2026, an estimated $42.8K.
  • Thermo Fisher Scientific made up 1.1% of Gilman Hill Asset Management's portfolio in Q3 2026, its #36 holding.
  • Gilman Hill Asset Management first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 27 quarters since.
  • 302 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Gilman Hill Asset Management's 13F filing for Q3 2026, filed 13 Oct 2026.